Sumitomo Mitsui Trust Group, Inc.
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 1475365
CHIYODA-KU, TOKYO, M0
Position in INDV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$464,049
-$5,952 QoQ
Shares Held
11,310
-26.7% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#205
of 334 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INDV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sumitomo Mitsui Trust Group, Inc. holds $237,661,566 across 8 Drug Manufacturers - Specialty & Generic names. INDV ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,340,457 | $79,294,683 | |
| 2 | ZTS |
Zoetis Inc.
|
1,020,052 | $73,300,936 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
85,496 | $46,324,297 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
215,488 | $36,318,347 | |
| 5 | VTRS |
Viatris Inc
|
99,887 | $1,586,205 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
11,310 | $464,049 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
7,715 | $267,479 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
10,557 | $105,570 |
All Filings in INDV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $464,049 | 11,310 | Shares | Defined | 2026-07-30 | |
| 2026-03-31 | $470,001 | 15,420 | Shares | Defined | 2026-04-30 | |
| No filing history on record for this holder in this stock. | ||||||